Our Portfolio

RemeGenix, Inc

Luciano D'Adamio, MD, PhD | NY

Project Overview

  • Biotechnology/For Profit Organization Type
  • $100,000 Funding Amount
  • 6/1/08 — 1/30/14 Project Duration
  • Drug Discovery Program
  • Lead Optimization Therapeutic Stage
  • Closed Status

RemeGenix, Inc

Luciano D'Adamio, MD, PhD | NY

Commercialization of BR12 peptides for AD

GET IN TOUCH